BCA
NVAX icon

Berman Capital Advisors’s Novavax NVAX Stock Holding History

Berman Capital Advisors’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$58K Buy
284
+221
+351% +$48.7K 0.01% 613
2021
Q2 		$13K Buy
63
+27
+75% +$4.95K ﹤0.01% 1059
2021
Q1 		$6K Buy
36
+33
+1,100% +$6.58K ﹤0.01% 1220
2020
Q4 		$0 Sell
3
-9
-75% -$957 ﹤0.01% 1775
2020
Q3 		$1K Buy
+12
New +$1.46K ﹤0.01% 1483

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Berman Capital Advisors's NVAX Position: Q3 2021 in Review

Berman Capital Advisors increased its Novavax (NVAX) stake by 351% in Q3 2021, buying an estimated $48.7K and bringing the position to 284 shares worth $58K. The position accounts for 0.01% of the portfolio, ranked #613.

Berman Capital Advisors first reported a position in NVAX in Q3 2020 and has held it in 5 quarters since. 443 funds tracked by Wall St. Rank hold NVAX as of Q3 2021.

  • Berman Capital Advisors held 284 shares of Novavax worth $58K as of Q3 2021.
  • Berman Capital Advisors bought 221 Novavax shares in Q3 2021, an estimated $48.7K.
  • Novavax made up 0.01% of Berman Capital Advisors's portfolio in Q3 2021, its #613 holding.
  • Berman Capital Advisors first reported a position in Novavax in Q3 2020 and has held it in 5 quarters since.
  • 443 funds tracked by Wall St. Rank held Novavax as of Q3 2021.

Based on Berman Capital Advisors's 13F filing for Q3 2021, filed 7 Oct 2021.